Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response
about
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityModulation of host adaptive immunity by hRSV proteinsThe non-structural NS1 protein unique to respiratory syncytial virus: a two-state folding monomer in quasi-equilibrium with a stable spherical oligomerRSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In VivoThe interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biologyDifferentiation of Th subsets inhibited by nonstructural proteins of respiratory syncytial virus is mediated by ubiquitination.Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells.Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacyRefining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genesAntiviral B cell and T cell immunity in the lungs.Protective and dysregulated T cell immunity in RSV infectionSubtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells.A gene expression signature for RSV: clinical implications and limitations.An overview of respiratory syncytial virus.Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.Viruses, autophagy genes, and Crohn's disease.Progress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsImmunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus.The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life ReinfectionsPreexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection.Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c miceNeutrophil in viral infections, friend or foe?Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β.Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration.Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infectionVirus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism.Respiratory syncytial virus infection and immunity.The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.Central nervous system alterations caused by infection with the human respiratory syncytial virus.New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.Viral manipulation of the host immune response.Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Modulation of the host immune response by respiratory syncytial virus proteins.
P2860
Q26748856-E9DFF9AD-99D6-489B-937D-CBFB24850E75Q27010165-FA587E9F-5896-417A-B7D0-2916B3C75140Q27022693-0F0A9017-8751-4297-99B9-59AEF83ED8AAQ28533165-970DC688-05E9-42E9-9BB6-C5CA36386DB0Q28548423-FDB50FB0-9457-4941-BB8C-12B20FD8FF30Q28728377-BEF76748-763C-4C29-9DB6-650A09166B18Q31172413-A65D46B4-12FC-4F82-A4BF-A3978B2298B7Q33566364-3B084D7C-01D5-4AAD-A0D8-AF1481932CFCQ34025263-5C1EC1F3-C028-43C9-8C2B-46F4F17C44CFQ34137781-30BF44A7-EC86-4AC5-9110-9D5DCF4985AEQ34166276-645FBB8C-5BC3-480A-9883-C59753F3A3A6Q34237741-DD3E3E06-8A6A-42CD-AFA7-07CF1C877932Q34454614-E6182D71-1844-49E9-BB6C-1826B9F922D9Q34964939-83F6F088-825D-46D5-A978-18F71F75141DQ34986260-6AF336F4-25D9-4CD3-AB34-6EDA6AA1A687Q35050237-68FD8A14-405F-47C3-8BBF-AC4435B54570Q35157041-189BAF7B-6FF2-45D3-A19D-08C36EFB49ACQ35185439-3DC2B3A4-295D-4DFA-8A43-AFC2DC2E5DC6Q35261483-9AD312D7-1201-4BA0-A6B5-DE2F8CB25555Q35566601-7412662E-FF22-4C29-BA57-9BE2211410DBQ35625850-06F0C72E-2B11-46EC-9B3C-3981050D41B5Q36216308-975DA35D-BB64-43FA-82C0-2E031C22FE20Q36274090-3362B40C-641F-441C-8149-B01261041EF8Q36276582-7402ED0E-5A97-4E08-B9B3-FE9D9DAE6F18Q36397412-3B02A5AB-855B-41DD-8194-FC00A1736AA3Q36569374-F465553E-F169-4999-9CFC-4A3AF50C3F1CQ36667922-2F62CED9-27F6-4733-AAEC-22AB7788C599Q36725539-12527995-4893-4FF2-8A04-B7BDE911E2FAQ36935746-B6B20D4F-798A-4F3D-A12C-2D3164E86208Q37003960-522A3413-2CE9-496C-A661-5532AA25F59EQ37619850-513E0FD7-BEF5-4074-B0B5-4F2223A62F41Q37698331-15D0EFC9-73D4-4B3D-9363-259756D8B430Q37980056-5159CCE8-42F6-47E8-BCC9-B89F73CA7DF1Q38068469-0F7F688B-C3E8-41CD-B72E-FBC271CC2DF7Q38260281-785541B4-0FFA-4FD8-A35B-3CF1036E3C5DQ38539476-5666A9EB-6ED4-4BBA-BEEB-31B77CD10873Q38547642-D3FEB70C-4E69-49F2-88F8-4DE0C1D0D293Q38600929-F602904A-5D86-458F-8065-14FD433CDBA0Q39027049-393E79F8-39C4-45CF-A8A3-3ED547C9B47BQ39154023-9DF8CE5D-DE91-4FCA-BFC6-4D947210B744
P2860
Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Respiratory syncytial virus in ...... he human T lymphocyte response
@ast
Respiratory syncytial virus in ...... he human T lymphocyte response
@en
type
label
Respiratory syncytial virus in ...... he human T lymphocyte response
@ast
Respiratory syncytial virus in ...... he human T lymphocyte response
@en
prefLabel
Respiratory syncytial virus in ...... he human T lymphocyte response
@ast
Respiratory syncytial virus in ...... he human T lymphocyte response
@en
P2093
P2860
P1433
P1476
Respiratory syncytial virus in ...... he human T lymphocyte response
@en
P2093
Alexander Bukreyev
Cyril Le Nouën
Peter L Collins
Philippa Hillyer
Ronald L Rabin
Shirin Munir
Ursula J Buchholz
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001336
P577
2011-04-21T00:00:00Z